Here are six quick facts on the transaction:
• 15,000 shares were sold
• Average share price was $45.53
• Total transaction value was $682,950
• Mr. Miles now directly owns 84,651 shares
• His shares are valued at around $3.8 million
The company traded down on Tuesday 0.87 percent, according to the report. NuVasive’s 52-week low is $31.35. Many new reports, including one from a Canaccord Genuity, place NuVasive stock at a “buy” rating.
More articles on orthopedic devices:
Double-digit growth for Precision Spine in 2014—5 key updates
SpineGuad gets FDA thumbs-up for PediGuard
K2M sets follow-on offering at $18.75 per share — 5 things to know
